Literature DB >> 27544483

Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.

Renata P Lerner1, Zisis Bimpisidis2, Stergiani Agorastos3, Sandra Scherrer4, Stephen L Dewey5, M Angela Cenci6, David Eidelberg7.   

Abstract

Dissociation of vasomotor and metabolic responses to levodopa has been observed in human subjects with Parkinson's disease (PD) studied with PET and in autoradiograms from 6-hydroxydopamine (6-OHDA) rat. In both species, acute levodopa administration was associated with increases in basal ganglia cerebral blood flow (CBF) with concurrent reductions in cerebral metabolic rate (CMR) for glucose in the same brain regions. In this study, we used a novel dual-tracer microPET technique to measure CBF and CMR levodopa responses in the same animal. Rats with unilateral 6-OHDA or sham lesion underwent sequential 15O-water (H215O) and 18F-fluorodeoxyglucose (FDG) microPET to map CBF and CMR following the injection of levodopa or saline. A subset of animals was separately scanned under ketamine/xylazine and isoflurane to compare the effects of these anesthetics. Regardless of anesthetic agent, 6-OHDA animals exhibited significant dissociation of vasomotor (ΔCBF) and metabolic (ΔCMR) responses to levodopa, with stereotyped increases in CBF and reductions in CMR in the basal ganglia ipsilateral to the dopamine lesion. No significant changes were seen in sham-lesioned animals. These data faithfully recapitulate analogous dissociation effects observed previously in human PD subjects scanned sequentially during levodopa infusion. This approach may have utility in the assessment of new drugs targeting the exaggerated regional vasomotor responses seen in human PD and in experimental models of levodopa-induced dyskinesia.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral blood flow; Glucose metabolism; Levodopa treatment; MicroPET; Parkinson's disease

Mesh:

Substances:

Year:  2016        PMID: 27544483      PMCID: PMC5102795          DOI: 10.1016/j.nbd.2016.08.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  24 in total

1.  Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.

Authors:  K Elisabet Ohlin; Irene Sebastianutto; Chris E Adkins; Cornelia Lundblad; Paul R Lockman; M Angela Cenci
Journal:  Neuroimage       Date:  2012-03-03       Impact factor: 6.556

Review 2.  Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.

Authors:  M Angela Cenci; Martin Lundblad
Journal:  J Neurochem       Date:  2006-08-29       Impact factor: 5.372

3.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

4.  Distribution of the dopamine innervation in the macaque and human thalamus.

Authors:  Miguel Angel García-Cabezas; Beatriz Rico; Miguel Angel Sánchez-González; Carmen Cavada
Journal:  Neuroimage       Date:  2006-11-30       Impact factor: 6.556

5.  Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists.

Authors:  L Edvinsson; J E Hardebo; J McCulloch; C Owman
Journal:  Adv Neurol       Date:  1978

6.  Cerebral circulatory and metabolic effects of piribedil.

Authors:  J McCulloch; L Edvinsson
Journal:  Eur J Pharmacol       Date:  1980-09-05       Impact factor: 4.432

7.  Levodopa treatment improves functional recovery after experimental stroke.

Authors:  Karsten Ruscher; Enida Kuric; Tadeusz Wieloch
Journal:  Stroke       Date:  2011-11-17       Impact factor: 7.914

8.  Influence of dopamine and noradrenaline on isolated cerebral arteries of the dog.

Authors:  N Toda
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

9.  Ketamine effects on local cerebral blood flow and metabolism in the rat.

Authors:  M Cavazzuti; C A Porro; G P Biral; C Benassi; G C Barbieri
Journal:  J Cereb Blood Flow Metab       Date:  1987-12       Impact factor: 6.200

10.  Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons.

Authors:  Domingo Afonso-Oramas; Ignacio Cruz-Muros; Javier Castro-Hernández; Josmar Salas-Hernández; Pedro Barroso-Chinea; Sonia García-Hernández; José L Lanciego; Tomás González-Hernández
Journal:  Front Neuroanat       Date:  2014-08-26       Impact factor: 3.856

View more
  4 in total

1.  Cerebral blood flow in dystonia due to pantothenate kinase-associated neurodegeneration.

Authors:  Peter Stoeter; Pedro Roa-Sanchez; Cesar F Gonzalez; Herwin Speckter; Jairo Oviedo; Pamela Bido
Journal:  Neuroradiol J       Date:  2020-08-27

2.  Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia.

Authors:  Vincent A Jourdain; Katharina A Schindlbeck; Chris C Tang; Martin Niethammer; Yoon Young Choi; Daniel Markowitz; Amir Nazem; Dominic Nardi; Nicholas Carras; Andrew Feigin; Yilong Ma; Shichun Peng; Vijay Dhawan; David Eidelberg
Journal:  JCI Insight       Date:  2017-10-19

3.  Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia.

Authors:  Renata P Lerner; Veronica Francardo; Koji Fujita; Zisis Bimpisidis; Vincent A Jourdain; Chris C Tang; Stephen L Dewey; Thomas Chaly; M Angela Cenci; David Eidelberg
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

4.  Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats.

Authors:  Edward J R Fletcher; Clare J Finlay; Ana Amor Lopez; William R Crum; Anthony C Vernon; Susan Duty
Journal:  Front Neurosci       Date:  2020-09-15       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.